# A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

> **NCT01065805** · PHASE1,PHASE2 · TERMINATED · sponsor: **AHS Cancer Control Alberta** · enrollment: 94 (actual)

## Conditions studied

- Brain Cancer
- Cancer
- Solid Tumor
- Lymphoma

## Interventions

- **BIOLOGICAL:** 18F-FLT

## Key facts

- **NCT ID:** NCT01065805
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03-20
- **Primary completion:** 2019-02-25
- **Final completion:** 2019-02-25
- **Target enrollment:** 94 (ACTUAL)
- **Why stopped:** Retirement of former Qualified Investigator and lack of resources to complete study
- **Last updated:** 2019-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01065805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01065805, "A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01065805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*